Coya Therapeutics, Inc. (COYA:NASDAQ) closed at $4.25 on October 16, 2026, down 2.07% on the day. The stock trades 43.7% below its 52-week high of $7.55 and 14.6% above its 52-week low of $3.71. Over the past year, it lost 33.2%. Coya Therapeutics, Inc. is part of the Health Care sector.
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -11.64% | -10.71% | -4.28% | -14.83% | -33.18% |
In 252 trading sessions since October 16, 2025, COYA closed higher on 115 days (46%). Its best day was May 14, 2026 (+15.86%) and its worst was January 15, 2026 (-13.15%). The stock moved 10% or more in a single session 5 times.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
Find more stocks like COYA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.